| Issuer | % of Class | Filed |
|---|---|---|
|
ADC Therapeutics SA
13G
ADCT · H0036K147
|
10.0% |
10/29/2026
Event 10/22/2026
|
|
Olema Pharmaceuticals, Inc.
13G/A
Amendment 4
OLMA · 68062P106
|
8.2% |
5/15/2026
Event 3/31/2026
|
|
Olema Pharmaceuticals, Inc.
13G/A
Amendment 3
OLMA · 68062P106
|
10.0% |
2/17/2026
Event 12/31/2025
|
|
Olema Pharmaceuticals, Inc.
13G/A
Amendment 2
OLMA · 68062P106
|
10.0% |
5/15/2025
Event 3/31/2025
|
|
Olema Pharmaceuticals, Inc.
13G/A
Amendment 1
OLMA · 68062P106
|
10.0% |
1/13/2025
Event 1/8/2025
|
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.